OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0936-AA08 View EO 12866 Meetings | Received Date: 11/13/2020 |
| Title: Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection | |
| Agency/Subagency: HHS / OIG | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 11/18/2020 |
| Legal Deadline: None | Economically Significant: Yes |
| Publication Date: 11/30/2020 | Unfunded Mandates: State, local, or tribal governments |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: No |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



